Cite
HARVARD Citation
Kanter, J. et al. (2023). Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study. American journal of hematology. 98 (1), pp. 11-22. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kanter, J. et al. (2023). Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study. American journal of hematology. 98 (1), pp. 11-22. [Online].